# Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant

> **NCT03458897** · NA · COMPLETED · sponsor: **University of Michigan** · enrollment: 7 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DIAGNOSTIC_TEST:** serial functional magnetic resonance imaging (MRI)

## Key facts

- **NCT ID:** NCT03458897
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-03
- **Primary completion:** 2020-08-16
- **Final completion:** 2020-09-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03458897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03458897, "Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03458897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*